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Acupuncture is emerging as an alternative therapy for rheumatoid arthritis (RA). However, the molecular mechanism underlying
this beneﬁcial eﬀect of acupuncture has not been fully understood. Here, we demonstrated that electroacupuncture at acupoints
Zusanli (ST36), Xuanzhong (GB39); and Shenshu (BL23) markedly decreased the paw swelling and the histologic scores of
inﬂammation in the synovial tissue, and reduced the body weight loss in an adjuvant-induced arthritis rat model. However, the
electrical stimulation at nonacupoint did not produce any beneﬁcial eﬀects against the experimental arthritis. Most interestingly,
the electroacupuncture treatment resulted in an enhanced immunostaining for vasoactive intestinal peptide (VIP), a potent
anti-inﬂammatory neuropeptide, in the synovial tissue. Moreover, the VIP-immunostaining intensity was signiﬁcantly negatively
correlated with the scores of inﬂammation in the synovial tissue (r =− 0.483, P = .0026). In conclusion, these ﬁndings suggest
that electroacupuncture may oﬀer therapeutic beneﬁts for the treatment of RA, at least partially through the induction of VIP
expression.
1.Introduction
In China, acupuncture has been used to treat a variety
of health problems for more than 5000 years. Nowadays,
this traditional Chinese medical technique has become very
popular worldwide as a complementary medicine [1]. Some
of the common applications of acupuncture include heart
disease [2], smoking cessation [3], and the treatment of
inﬂammatory diseases such as rheumatoid arthritis (RA)
[4–7], autonomic dysfunction [8–10], neurological diseases
[11],neuropathicpains[12–14],drugaddiction[15,16],and
psychological disorders [17, 18]. Although neuroendocrine-
immune, gene expression; and proteomic analysis have been
employed and provided some molecular interpretations
in many experiments about electroacupuncture (EA), the
molecular mechanism of acupuncture is still not clear [19].
RA is a systemic inﬂammatory disorder that mainly
aﬀectsthediarthrodialjoint.Althoughacupuncturehasbeen
clinically used to treat the patients with RA, the mechanism
underlying the beneﬁcial eﬀects of acupuncture is still
unclear. Some researchers have suggested that the action
of acupuncture may be associated with the improvement
of tissue function through vasodilatation in the skin due
to axon reﬂexes [20]. Neuroendocrine-immune interactions
have been proposed to contribute to the pathogenesis of
RA. Vasoactive intestinal peptide (VIP) has been found to
act as a potent anti-inﬂammatory factor in experimental
arthritis through regulating the production of both anti-
and proinﬂammatory mediators and promoting Th2-type
responses [21]. Additionally, VIP can negatively regulate
the Toll-like receptor 4-signaling in rheumatoid arthritis
synovial ﬁbroblasts [22]. Many studies have documented
that the VIP levels can be modulated by acupuncture.
Acupuncture at Zusanli (ST36) has been reported to cause
an elevation of VIP levels in plasma, gastric mucosal and,
bulb tissues in rats [23]. In contrast, EA at Tianshu (ST-25)2 Evidence-Based Complementary and Alternative Medicine
in combination with Tegaserod administration into the
stomach can inhibit the secretion of VIP in rats with irritable
b o w e ls y n d r o m e[ 8]. Given the modulation of VIP by
acupuncture and the importance of VIP in experimental
arthritis, we hypothesized that the action of acupuncture on
RA may be attributable to the elevation of VIP expression
and the subsequent suppression of the arthritis. To test this
hypothesis, we established a Freund’s complete adjuvant-
(FCA-) induced arthritis model in rats and evaluated the
eﬀects of EA at Zusanli (ST36), Xuanzhong (GB39) and
Shenshu(BL23) onthe arthritis andthe expression of VIP.In
addition, the relationship between the inﬂammation scores
and VIP levels was analyzed. The above acupoints were
chosen in this study because they are commonly used in the
treatment of arthritis through acupuncture, and they have
the eﬀects of anti-inﬂammatory, reduce pain, and modulate
neuroendocrine-immune system [20, 24–27].
2.MaterialsandMethods
2.1. Animals. Wistar rats (male, 5-6 weeks old) were pur-
chased from Shanghai SLAC laboratory animal co., Ltd.,
Shanghai, China. Following adaptation for 1 week, rats
were randomly divided into 5 groups (n = 15 for each
group): the saline control group (injection of saline), the
FCA group (injection of FCA to induce arthritis), the FCA-
EA group (injection of FCA followed by EA stimulation
at ST36, GB39, and BL23), the saline-EA group (injection
of saline followed by EA stimulation at ST36, GB39, and
BL23), and the FCA-EA (nonacupoint) group (injection
of FCA followed by EA treatment at a nonacupoint). All
experimental manipulations were undertaken in accordance
with the National Institutes of Health Guide for the Care
and Use of Laboratory Animals, and with the approval of the
Scientiﬁc Investigation Board of the Shanghai University of
Traditional Chinese Medicine, Shanghai, China.
2.2. Induction of Arthritis by FCA. Experimental arthritis
was induced as described previously [28, 29]. Brieﬂy, rats
were anesthetized with 4% halothane in oxygen, and the
right hindlimb footpad received an injection of 0.1mL
FCA (Sigma, St. Louis, MO, USA), which contains 0.1mg
heat-killed and dried Mycobacterium tuberculosis (strain
H37Ra, ATCC 25177), 85μLp a r a ﬃno i la n d1 5μL mannide
monooleate. Rats in the control groups were injected with
equal volume of saline instead of FCA. The inoculation day
was designated as day 0.
2.3. EA Stimulation. Three days following the FCA admin-
istration, EA stimulation was performed as described pre-
viously [27]. Brieﬂy, small cages with ﬁve holes for four
limbs and a tail were built. During the EA treatment,
animals were maintained within the cage with right hind
limb taken out and fastened to the wall of the cage with
tape. Sterilized disposable stainless steel acupuncture needles
(0.30 × 25mm, Suzhou Kangnian Medical Devices Co., Ltd.,
Suzhou, China) were inserted perpendicularly as deep as 2-




Figure 1: Schematic diagram indicates the three selected acupoints,
Xuanzhong (GB39), Shenshu (BL23) and Zusanli (ST36), which
correspond to equivalent acupoints in humans.
7mm at Zusanli (ST36). The depth of needle insertion into
each acupoint was arbitrarily determined based on several
previous studies [24, 30, 31]. The locations of the acupoints
were illustrated in Figure 1; that is, GB39 is located at the
distal 4/5 point on the line connecting the lateral side of the
knee and the lateral malleolus of the tibioﬁbula, BL23 at the
depression lateral to the lower border of spinous process of
the second lumbar vertebra, and ST36 at the proximal 1/5
site of craniolateral surface of the leg distal to the head of
the tibia in a depression between the muscles of the cranial
tibia and the long digital extensor. The needles inserted into
the acupoints were connected to an EA stimulator (Model
LH 202H HANS, Beijing Huawei LTD, Beijing, China), and
a constant electrical stimulus (2Hz, 0.2ms pulse width) was
applied for 15 minutes. The intensity (6-7mA) was adjusted
until local muscle contractions were seen. The EA treatment
was given once every other day for 15 days. To control for
the possible eﬀects of EA, some animals received an electrical
stimulation at a nonacupoint (the gluteal muscle), following
the same procedures as above. Additionally, the animals
without receiving EA stimulation were restricted in cages in
the same manner with the EA-stimulated animals.
2.4. Measurements of the Body Weight and the Paw Volume.
The body weight and the paw volume for each rat were
examined every 3 days for 18 days after adjuvant injection.
The paw volume was blindly measured using a water dis-
placement plethysmometer (YLS-7A, Yiyan Sci Ltd., Jinan,
China). The mean values were calculated and plotted at each
time point.
2.5. Hematoxylin and Eosin (H&E) Staining and Inﬂam-
mation Scoring. The ankle joint was removed from each
rat, washed in PBS, and ﬁxed with 10% formalin in PBS.
Paraﬃn-embedded sections (4μm) were deparaﬃnized in
xylene followed by rehydration through an ethanol gradient
todistilledwater.H&Estainingwasperformedonallsamples
for pathological examination. The stained sections were
scored by 2 investigators who were blinded to the treatments,
according to the following scale. 0, no inﬂammation; 1:
mild inﬂammatory inﬁltrate in skin and overlying tissues; 2:
dense inﬂammatory inﬁltrate but no synovitis or arthritis; 3:
synovitis; 4: hyperplastic synovium, inﬂammatory inﬁltrate
in the joint; 5. arthritis with destruction of articular tissues,
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Figure 2: Eﬀect of EA on the body weight and the paw swelling in adjuvant-induced arthritis Rats. (a) The body weight.
∗P <. 05, compared
with FCA-injected group. (b) The paw swelling.













Figure 3: Histological study of the inﬂammation of the synovial tissue. A very mild inﬂammation in the ankle joint from the animals in the
saline (a) and saline-EA (b) groups. Massive accumulation of inﬂammatory cells in the swollen joint (c) and an apparent periosteal edema
(d) are seen in the FCA-injected group. (e) Less inﬂammation and hyperplastic synovial cells are presence in the ankle joint of the animals
in the FCA-EA group. (f) A severe inﬂammation of the ankle joint is detected in the FCA-EA (nonacupoint) group. H&E staining; original
magniﬁcation, 400x.
2.6. VIP Radioimmunoassay. The concentration of VIP in
the serum of rats was determined by radioimmunoassay
according to the manufacturer’s protocol. [125I]-VIP for
the preparation of the labeled VIP and synthetic VIP as
standardwerepurchasedfromtheInstituteforNeuroscience,
Second Military Medical University (Shanghai, China). All
serum samples were assayed in duplicate and the mean
values were calculated. Individual controls for nonspeciﬁc
binding in the absence of antibody were also included.
The radioimmunoassay results were expressed as nano-
grams of immunoreactive peptide per milliliter of serum










































































































Figure 4: Histological scores of inﬂammation in the synovial tissue
from the indicated groups.
∗∗P <. 01, compared with the FCA
group. Data are means ± SD (n = 15).
2.7. RNA Isolation and Real-Time Quantitative RT-PCR
(qPCR). Total RNA was extracted from synovial tissues
with an RNeasy mini kit (Qiagen, Germany) according to
the manufacturer’s protocol, and cDNA was subsequently
synthesized from total RNA using the cDNA Synthesis
kit (Roche, Mannheim, Germany). The qPCRs for the
VIP or for the internal control glyceraldehyde-3-phosphate
dehydrogenase(GAPDH)wereperformedusingSYBR-green
detection of PCR products in an ABI-7500 Real-time Cycler
(ABI, Foster City, CA, USA). The cycling conditions were as
follows: initial denaturation at 95◦C for 10 minutes, then 40
cycles of denaturation at 95◦C for 5 seconds, annealing at
60◦C for 20 seconds, and elongation at 72◦C for 15 seconds.
The sequences of the primers for qPCR were as follows: sense
5 -TCA TTG GCA AAC GAA TCA GT-3  and antisense 5 -
ATT TGC TTT CTA AGG CGG GT-3  for VIP, and sense 5 -
GGC ATC CTG ACC CTG AAG TA-3  andantisense5 -GGG
GTG TTG AAG GTC TCA AA-3  for GAPDH.A l lq P C R s
were performed in triplicate. The relative amount of VIP,
normalized to the internal control GAPDH and relative to a
calibrator, was calculated according to a previously described
method [32].
2.8. Immunohistochemistry. Formalin-ﬁxed, paraﬃn-em-
bedded sections were deparaﬃnized and rehydrated in
graded alcohol, and antigen retrieval was achieved using
microwave heating. Sections were incubated with the
primary antibody against VIP (diluted 1:500) overnight
at 4◦C, followed by the incubation with EnVision Plus
System (Dako) as previously described [33]. Negative
controls were included by omitting the primary antibody,
and positive controls were added by including a known
positive tissue. The stained sections were independently
assessed by two pathologists without prior knowledge of
the experimental protocols. The immunostaining for VIP
was considered positive when the cytoplasm was stained
b r o w n .T h el e v e l so fi m m u n o r e a c t i v eV I Pp r o t e i nw e r e
quantiﬁed morphometrically using Image Pro-Plus 6.0
software (Media Cybernetics Inc., USA) on an Olympus
BX51 microscope (Japan). Five random ﬁelds on each slide
at 400x magniﬁcation were analyzed, and the mean optical
density was calculated.
2.9.StatisticsAnalysis. Allstatisticalcalculationswerecarried
out using SPSS 13.0 software (SPSS, Chicago, IL, USA). The
data were presented as mean ± SD. Statistical analysis was
evaluated by one-way ANOVA and post hoc tests. Spearman
bivariate correlation was used to determine the relation
between the VIP protein expression and inﬂammation scores
in the synovial tissue. A level of P<. 05 was considered
statistically signiﬁcant.
3. Results
3.1. Alleviation of the FCA-Induced Body Weight Loss and
Paw Swelling. The average body weight was signiﬁcantly
decreased in the animals with adjuvant-induced arthritis as
compared with that in the saline control group. The EA
at acupoints substantially alleviated the body weight loss
caused by the FCA injection (P<. 05 versus the FCA
group; Figure 2(a)). However, the electrical stimulation at
nonacupoint had little inﬂuence on the FCA-elicited body
weight reduction. Accompanying with the body weight loss,
apronouncedinductionofpawswellingwasfoundfollowing
the FCA injection (Figure 2(b)). Interestingly, the FCA-
induced paw swelling was signiﬁcantly lowered by the EA
at acupoints (P<. 05 versus the FCA group), but not by
the EA at nonacupoint. Additionally, the EA stimulation at
the studied acupoints did not elicit any signiﬁcant eﬀects in
saline-treated animals.
3.2. The Attenuation of FCA-Induced Inﬂammation. Histo-
logical analysis of sections of the ankle joint revealed little
or no sign of inﬂammation in the saline (Figure 3(a))a n d
saline-EA(Figure 3(b))groups.Incontrast,theFCA-injected
animals displayed massive accumulation of inﬂammatory
cells in the swollen joint (Figure 3(c)) and an apparent
periosteal edema (Figure 3(d)). The FCA-induced joint
inﬂammation was considerably inhibited by the EA stim-
ulation (Figure 3(e)). However, the electrical stimulation
at nonacupoint did not oﬀer any beneﬁcial eﬀects on
the control of inﬂammation (Figure 3(f)). Semiquantitative
analysisconﬁrmedthesigniﬁcantinhibitionofinﬂammation
by EA at the acupoints (P<. 01 as compared with the FCA
group; Figure 4), suggesting a speciﬁc role for EA in the
control of pathological inﬂammatory responses.
3.3. Upregulation of the VIP mRNA Expression in the Synovial
Tissue. The results of qPCR analysis demonstrated a 2.6-fold
higher amount of VIP mRNA in the synovial tissue in the
FCA-EA group than in the FCA group (P<. 01; Figure 5(a)).











































































































































































































Figure 5: Examination of the serum and synovial VIP contents. (a) qPCR analysis of the expression of VIP mRNA in the synovial tissue.
(b) No statistical diﬀerence in the serum VIP concentrations are found among the indicated groups.
∗∗P <. 01, compared with the FCA













Figure 6: Immunostaining for VIP in the synovial tissue. Histological analysis of the synovial tissue from the saline group shows weak
staining for VIP in synovial cells (a) and moderate staining for VIP in endothelium, smooth muscle, and nerve ﬁbers (b). (c) Synovial cells
from the saline-EA group display weak immunoreaction for VIP. (d) Moderate to strong immunostaining for VIP is seen in the synovial
tissue from the FCA-injected animals. An enhancement of the VIP immunoreactivity in the synovial tissue is observed in the FCA-EA group
(e) but not in the FCA-EA (nonacupoint) group (f). Original magniﬁcation, 400x.
slightly decreased following the EA treatment, but there
was no statistical diﬀerence between the FCA and FCA-EA
groups (Figure 5(b)). Additionally, no signiﬁcant diﬀerence
in the synovial VIP mRNA and serum VIP protein levels
was detected among the saline, FCA, saline-EA, and FCA-EA
(nonacupoint) groups.
3.4. Enhanced Immunostaining for VIP in the Synovial Tissue.
Histological analysis of the synovial tissue from the saline
group showed weak staining for VIP in synovial cells
(Figure 6(a)) and moderate staining for VIP in endothelium,
smooth muscle, and nerve ﬁbers (Figure 6(b)). Likewise,







































































































Figure 7: The integral optical density (IOD) of VIP immunoreac-
tivity in the synovial tissue.
∗∗P <. 01, compared with the FCA
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Figure 8: Relationship between the VIP immunostaining intensity
and the scores of inﬂammation in the synovial tissue in rats with
adjuvant-induced arthritis. n = 15.
immunoreaction for VIP in synovial cells (Figure 6(c)).
Moderate to strong immunostaining for VIP was seen in the
synovial tissue from the FCA-injected animals (Figure 6(d)).
Most interestingly, the EA treatment resulted in a profound
enhancement of the VIP immunoreactivity in the synovial
tissue (Figure 6(e)). However, the electrical stimulation at
nonacupoint had little inﬂuence on the VIP expression in
the synovial tissue (Figure 6(f)). The results of the computer
image analysis further demonstrated the EA treatment
following FCA signiﬁcantly increased the VIP expression
in the synovial tissue in comparison with the FCA alone
(116.46 ± 57.88 versus 59.27 ± 16.86, P<. 01; Figure 7). No
signiﬁcant diﬀerence was detected among the saline, FCA,
saline-EA, and FCA-EA (nonacupoint) groups.
3.5. The Relationship between the EA-Elicited Anti-Inﬂamma-
tory Eﬀects and the VIP Levels. To determine whether there
is a positive or negative correlation between VIP expression
and the scores of inﬂammation, Spearman bivariate corre-
lation analysis was conducted. As shown in Figure 8, the
VIP-immunostaining intensity was signiﬁcantly negatively
correlated with the scores of inﬂammation in the synovial
tissue (r =− 0.483, P = .0026), suggesting that the anti-
inﬂammatory eﬀects of EA at acupoint may be mediated
through the up-regulation of VIP expression.
4. Discussion
In the present study, we established an FCA-induced arthritis
model in rats and evaluated the eﬀects of EA stimula-
tion on the experimental arthritis. Our data show that
the EA at acupoints (ST36, GB39 and BL23) remarkably
reduced the body weight loss and alleviated the inﬂam-
mation and paw swelling induced by FCA injection. In
contrast, the EA stimulation at the above acupoints did
not elicit any signiﬁcant eﬀects in saline-treated animals,
suggesting a speciﬁc role for EA in the control of patho-
logical inﬂammatory responses. Accompanying with the
anti-inﬂammatory action, EA treatment resulted in an
enhancement of VIP expression in the synovial tissue.
Moreover, the VIP-immunostaining intensity was negatively
correlated with the inﬂammatory scores in the synovial
tissue. These ﬁndings collectively suggest a potentially
importantroleforVIPinmediatingtheantiarthriticeﬀectof
EA.
As a traditional Chinese medical technique, acupuncture
has become very popular worldwide in the treatment of vari-
ous illnesses [1]. Several lines of evidence have demonstrated
that it is eﬀective in treating pain and dysfunction in patients
with osteoarthritis of the knee [34, 35]. In a rat model
of collagen-induced arthritis, bee venom acupuncture has
been reported to be able to relieve inﬂammatory pain [36].
Our present data consistently indicate that EA at acupoints
can control the FCA-evoked experimental arthritis. The EA
eﬀects seem to be acupoint speciﬁc, since the electrical
stimulation at nonacupoint did not produce any beneﬁcial
outcome. This hypothesis is supported by a previous study
[37],whereimmunomodulatoryeﬀectsareexertedbytheEA
stimulation at acupoint ST36 but not at a nonacupoint (tail).
The nervous system has been reported to be involved
in the regulation of the pathogenesis of RA, through the
production of several neuropeptides such as somatostatin,
VIP, and calcitonin gene-related peptide [38]. VIP has been
proved as a potent anti-inﬂammation molecule in several
modelsofinﬂammatorydisease[39].Ourdatademonstrated
that VIP likely act as an important mediator of the anti-
inﬂammatory role of EA, which was supported by the
ﬁndings that the EA treatment could markedly enhanced
the expression of VIP in the synovial tissue, and moreover,
the synovial VIP levels were negatively correlated with the
inﬂammation scores. The migration of leukocytes into the
synovial tissue is one of the hallmarks of chronic inﬂam-
matory rheumatic diseases such as RA. The involvement
of VIP in the anti-inﬂammatory action of EA is likely
through the inhibition of lymphocyte inﬁltration, since
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Figure 9: A hypothetical diagram illustrating the EA action mediated by VIP in adjuvant-induced arthritis. EA stimulation at speciﬁc
acupoints promotes the expression and release of VIP, which in turn suppresses the production of proinﬂammatory cytokines and
chemokines (e.g., MCP-1, IL-6, and IL-8) by synovial cells and/or induces regulatory T cells (Treg) expansion, ultimately leading to the
inhibition of lymphocyte proliferation, activation, and inﬁltration and the alleviation of inﬂammatory responses.
proinﬂammatorycytokines and chemokines by synovialcells
in RA [38, 40]. Another alternative mechanism responsible
for the VIP function is the modulation of autoreactive
T cell activation/expansion through inducing a Th2-type
responseandexpandingCD4+CD25+ regulatoryTcells[21].
A hypothetical diagram of the anti-inﬂammatory action of
EA mediated by VIP in RA is shown in Figure 9.
In conclusion, our results indicated, for the ﬁrst time,
that the EA treatment at Zusanli (ST 36), Xuanzhong
(GB39), and Shenshu (BL23) could decrease the body weight
loss and suppress the paw edema and inﬂammatory reaction
in rats with Freund’s adjuvant-induced arthritis, at least
partially, via upregulating the VIP expression. These results
might provide an alternative therapy for RA. Further studies
willbenecessarytodeterminetheextenttowhichthepresent
ﬁndings are applicable to RA patients.
Acknowledgments
This project was supported by grants from the Shanghai
Municipal Natural Science Foundation (no. 07ZR14100),
and the Shanghai Key Discipline Construction Project-
Traditional Chinese Gynecological Medicine (no. S30303)
to Y.-F. Chen. The authors declare they have no competing
interests.
References
[1] F. J. Zijlstra, I. Van Den Berg-De Lange, F. J. P. M. Huygen,
and J. Klein, “Anti-inﬂammatory actions of acupuncture,”
Mediators of Inﬂammation, vol. 12, no. 2, pp. 59–69, 2003.
[2] J.-H. Lin, C.-H. Shih, K. Kaphle et al., “Acupuncture eﬀects
on cardiac functions measured by cardiac magnetic resonance
imaging in a feline model,” Evidence-Based Complementary
and Alternative Medicine, vol. 7, no. 2, pp. 169–176, 2010.
[3] C. Lambert, I. Berlin, T. L. Lee, et al., “A standardized tran-
scutaneous electric acupoint stimulation for relieving tobacco
urges in dependent smokers,” Evidence-Based Complementary
and Alternative Medicine. In press.
[4] M. Ogasawara, K. Oda, K. Yamaji, and Y. Takasaki, “Polyartic-
ular septic arthritis with bilateral psoas abscesses following
acupuncture,” Acupuncture in Medicine, vol. 27, pp. 81–82,
2009.
[5] M. Sato, M. Inubushi, T. Shiga et al., “Therapeutic eﬀects
of acupuncture in patients with rheumatoid arthritis: a
prospective study using 18F-FDG-PET,” Annals of Nuclear
Medicine, vol. 23, no. 3, pp. 311–316, 2009.
[ 6 ] S .T .K i m ,Y .J .K i m ,J .Y .L e ee ta l . ,“ A c u p un c t u r e
enhances superoxide dismutase (SOD) activity in the serum
of rheumatoid arthritis patients,” Clinical and Experimental
Rheumatology, vol. 27, no. 2, p. 384, 2009.
[ 7 ]S .D .A .Z a n e t t e ,I .G .B o r n ,J .C .T .B r e n o l ,a n dR .M .
Xavier, “A pilot study of acupuncture as adjunctive treatment
of rheumatoid arthritis,” Clinical Rheumatology, vol. 27, no. 5,
pp. 627–635, 2008.
[8] H.-G. Wu, B. Jiang, E.-H. Zhou et al., “Regulatory mechanism
ofelectroacupunctureinirritablebowelsyndrome:preventing
MC activation and decreasing SP VIP secretion,” Digestive
Diseases and Sciences, vol. 53, no. 6, pp. 1644–1651, 2008.
[9] S.-L. Tian, X.-Y. Wang, and G.-H. Ding, “Repeated electro-
acupuncture attenuates chronic visceral hypersensitivity and
spinal cord NMDA receptor phosphorylation in a rat irritable
bowel syndrome model,” Life Sciences, vol. 83, no. 9-10, pp.
356–363, 2008.
[10] F. Zeng, W.-Z. Song, X.-G. Liu et al., “Brain areas involved
in acupuncture treatment on functional dyspepsia patients: a
PET-CT study,” Neuroscience Letters, vol. 456, no. 1, pp. 6–10,
2009.
[11] Y.-G. Choi, J.-H. Park, and S. Lim, “Acupuncture inhibits
ferric iron deposition and ferritin-heavy chain reduction in
an MPTP-induced parkinsonism model,” Neuroscience Letters,
vol. 450, no. 2, pp. 92–96, 2009.
[12] R. Taguchi, “Acupuncture anesthesia and analgesia for clinical
acute pain in Japan,” Evidence-Based Complementary and
Alternative Medicine, vol. 5, no. 2, pp. 153–158, 2008.
[13] L. Aloe and L. Manni, “Low-frequency electro-acupuncture
reduces the nociceptive response and the pain mediator
enhancement induced by nerve growth factor,” Neuroscience
Letters, vol. 449, no. 3, pp. 173–177, 2009.
[14] M. S. Lee, B.-C. Shin, S.-M. Choi, and J. Y. Kim, “Random-
ized clinical trials of constitutional acupuncture: a system-
atic review,” Evidence-Based Complementary and Alternative
Medicine, vol. 6, supplement 1, pp. 59–64, 2009.
[15] C. H. Yang, B. H. Lee, and S. H. Sohn, “A possible mechanism
underlying the eﬀectiveness of acupuncture in the treatment8 Evidence-Based Complementary and Alternative Medicine
of drug addiction,” Evidence-Based Complementary and Alter-
native Medicine, vol. 5, no. 3, pp. 257–266, 2008.
[16] C.-L. Cui, L.-Z. Wu, and F. Luo, “Acupuncture for the
treatment of drug addiction,” Neurochemical Research, vol. 33,
no. 10, pp. 2013–2022, 2008.
[17] Z. Dong, L. Shun-Yue, W. Shu-You, and M. Hui-Min, “Eval-
uation of inﬂuence of acupuncture and electro-acupuncture
for blood perfusion of stomach by laser doppler blood perfu-
sion imaging,” Evidence-Based Complementary and Alternative
Medicine. In press.
[18] E.Noguchi,“Mechanismofreﬂexregulationofthegastroduo-
denal function by acupuncture,” Evidence-Based Complemen-
tary and Alternative Medicine, vol. 5, no. 3, pp. 251–256, 2008.
[19] E. L. Cooper, “eCAM: neuroendocrineimmune, electroacu-
puncture and gene expression,” Evidence-Based Complemen-
tary and Alternative Medicine, vol. 7, no. 2, pp. 149–150, 2010.
[20] M. S. Lee, B.-C. Shin, and E. Ernst, “Acupuncture for
rheumatoid arthritis: a systematic review,” Rheumatology, vol.
47, no. 12, pp. 1747–1753, 2008.
[ 2 1 ]G .C h e n ,J .H a o ,Y .X ie ta l . ,“ T h et h e r a p e u t i ce ﬀect of
vasoactive intestinal peptide on experimental arthritis is
associated with CD4+CD25+ Tr e g u l a t o r yc e l l s , ”Scandinavian
Journal of Immunology, vol. 68, no. 6, pp. 572–578, 2008.
[22] A. Arranz, I. Guti´ errez-Ca˜ nas, M. Carri´ on et al., “VIP reverses
the expression proﬁling of TLR4-stimulated signaling path-
way in rheumatoid arthritis synovial ﬁbroblasts,” Molecular
Immunology, vol. 45, no. 11, pp. 3065–3073, 2008.
[23] G.-M. Shen, M.-Q. Zhou, G.-S. Xu, Y. Xu, and G. Yin,
“Role of vasoactive intestinal peptide and nitric oxide in
the modulation of electroacupucture on gastric motility in
stressed rats,” World Journal of Gastroenterology, vol. 12, no.
38, pp. 6156–6160, 2006.
[24] L. Kuai, H. Y. Yang, T. Y. Liu, and M. Gao, “Analgesic eﬀects
of electroacupuncture of diﬀerent pulse waveforms in the rat
of adjuvant arthritis,” Zhongguo Zhen Jiu, vol. 25, pp. 68–71,
2005.
[25] Y. Yin, H. X. Zhang, and T. F. Zhang, “Clinical observation on
electroacupuncture combined with medicine for treatment of
acutegoutyarthritis,”ZhongguoZhenJiu,vol.25,pp.683–685,
2005.
[ 2 6 ]J .Q .F a n g ,X .M .S h a o ,a n dG .Z .M a ,“ E ﬀect of elec-
troacupuncture at ”Zusanli” (ST 36) and ”Sanyinjiao” (SP 6)
on collagen-induced arthritis and secretory function of knee-
joint synoviocytes in rats,” Zhen Ci Yan Jiu,v o l .3 4 ,n o .2 ,p p .
93–96, 2009.
[27] Y.-K. Yim, H. Lee, K.-E. Hong et al., “Electro-acupuncture at
acupoint ST36 reduces inﬂammation and regulates immune
activity in Collagen-Induced Arthritic Mice,” Evidence-Based
Complementary and Alternative Medicine, vol. 4, no. 1, pp. 51–
57, 2007.
[28] N. L. Chillingworth and L. F. Donaldson, “Characterisation
of a Freund’s complete adjuvant-induced model of chronic
arthritis in mice,” Journal of Neuroscience Methods, vol. 128,
no. 1-2, pp. 45–52, 2003.
[29] U.Heilborn,O.-G.Berge,L.Arborelius,andE.Brodin,“Spon-
taneous nociceptive behaviour in female mice with Freund’s
complete adjuvant- and carrageenan-induced monoarthritis,”
Brain Research, vol. 1143, no. 1, pp. 143–149, 2007.
[ 3 0 ]Y . - S .K i m ,C .K i m ,M .K a n g ,J .Y o o ,a n dY .H u h ,“ E l e c t r o a -
cupuncture-related changes of NADPH-diaphorase and neu-
ronal nitric oxide synthase in the brainstem of spontaneously
hypertensive rats,” Neuroscience Letters, vol. 312, no. 2, pp. 63–
66, 2001.
[31] C. S. Yin, H.-S. Jeong, H.-J. Park et al., “A proposed transposi-
tional acupoint system in a mouse and rat model,” Research in
Veterinary Science, vol. 84, no. 2, pp. 159–165, 2008.
[32] K. J. Livak and T. D. Schmittgen, “Analysis of relative gene
expression data using real-time quantitative PCR and the 2-
ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
[33] W. K. Lau, W. K. Chan, J. L. Zhang, K. K. L. Yung, and
H. Q. Zhang, “Electroacupuncture inhibits cyclooxygenase-2
up-regulation in rat spinal cord after spinal nerve ligation,”
Neuroscience, vol. 155, no. 2, pp. 463–468, 2008.
[34] S. M. Ling, “Does acupuncture improve symptoms in patients
with osteoarthritis who are awaiting knee replacement
surgery?” Nature Clinical Practice Rheumatology, vol. 4, no. 6,
pp. 286–287, 2008.
[35] C. Witt, B. Brinkhaus, S. Jena et al., “Acupuncture in patients
withosteoarthritisoftheknee:arandomisedtrial,”Lancet,vol.
366, no. 9480, pp. 136–143, 2005.
[36] Y. H. Baek, J. E. Huh, J. D. Lee, D. Y. Choi, and D. S. Park,
“Antinociceptive eﬀect and the mechanism of bee venom
acupuncture (Apipuncture) on inﬂammatory pain in the
rat model of collagen-induced arthritis: mediation by α2-
Adrenoceptors,” Brain Research, vol. 1073-1074, no. 1, pp.
305–310, 2006.
[37] S. K. Kim, Y. Lee, H. Cho, et al., “A parametric study on the
immunomodulatory eﬀects of electroacupuncture in DNP-
KLH immunized mice,” Evidence-Based Complementary and
Alternative Medicine. In press.
[38] Y. Takeba, N. Suzuki, A. Kaneko, T. Asai, and T. Sakane,
“Evidence for neural regulation of inﬂammatory synovial
cell functions by secreting calcitonin gene-related peptide
and vasoactive intestinal peptide in patients with rheumatoid
arthritis,” Arthritis and Rheumatism, vol. 42, no. 11, pp. 2418–
2429, 1999.
[39] L. Pulsatelli, P. Dolzani, T. Silvestri et al., “Synovial expression
of vasoactive intestinal peptide in polymyalgia rheumatica,”
Clinical and Experimental Rheumatology, vol. 24, no. 5, pp.
562–566, 2006.
[40] M. G. Juarranz, B. Santiago, M. Torroba et al., “Vasoac-
tive intestinal peptide modulates proinﬂammatory mediator
synthesis in osteoarthritic and rheumatoid synovial cells,”
Rheumatology, vol. 43, no. 4, pp. 416–422, 2004.